FdaApplication
ANDA 219922
Identifiers
- fda_app_no: ANDA219922
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-09-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAZOPANIB HYDROCHLORIDE | PAZOPANIB HYDROCHLORIDE | EQ 400MG BASE | TABLET;ORAL |
1 product